Maintenance Therapy in Advanced Ovarian Cancer: Progression-Free Survival and Clinical Benefit
- 1 July 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (13) , 2451-2453
- https://doi.org/10.1200/jco.2003.03.039
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group TrialJournal of Clinical Oncology, 2003
- High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right StudyGynecologic Oncology, 2003
- Tamoxifen Therapy for Ovarian Cancer in the Adjuvant and Advanced Settings: Systematic Review of the Literature and Implications for Future ResearchGynecologic Oncology, 2002
- Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-UpJournal of Clinical Oncology, 2002
- Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)Gynecologic Oncology, 2001
- Whole Abdominal Radiotherapy Following Second-Look Laparotomy for Ovarian CarcinomaGynecologic Oncology, 1999
- A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)Gynecologic Oncology, 1993
- Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaGynecologic Oncology, 1992
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast CancerNew England Journal of Medicine, 1991
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987